Skip to content

Interoception Underlies The Therapeutic Effects of Mindfulness Meditation for Post-Traumatic Stress Disorder: A Randomized Clinical Trial

Seung Suk Kang, Scott R Sponheim, Kelvin O Lim, M. D

arXiv Preprint Archive October 12, 2020 preprint

Study at a glance

AI-extracted from the abstract
Characteristics Randomized clinical trial
Sample size 98
Population Veterans with PTSD
Interventions Mindfulness-based stress reduction Present-centered group therapy
Duration Pre- and post-intervention
Topics PTSD Meditation
Keywords Q-bio.nc Mindfulness-meditation Trauma-therapy
Key findings Enhanced interoceptive brain responses, specifically frontal theta heartbeat-evoked potentials, mediated the therapeutic effect of mindfulness-based stress reduction on PTSD symptoms.

Abstract

Mindfulness-based interventions have proven its efficacy in treating post-traumatic stress disorder (PTSD), but the underlying neurobiological mechanism is unknown. To determine the neurobiological mechanism of action of mindfulness-based stress reduction (MBSR) treating PTSD, we conducted a randomized clinical trial (RCT) in which 98 veterans with PTSD were randomly assigned to receive MBSR therapy (n = 47) or present-centered group therapy (PCGT; n = 51; an active-control condition). Pre- and post-intervention measures of PTSD symptom severity (PTSD Checklist) and brain activity measures of electroencephalography (EEG) were assessed, including spectral power of spontaneous neural oscillatory activities during resting and meditation periods, time-frequency (TF) power of cognitive task-related brain responses, and TF power of heartbeat-evoked brain responses (HEBR) that reflect cardiac interoceptive brain responses during resting and meditation. Compared to controls, the MBSR group had greater improvements in PTSD symptoms, spontaneous EEG alpha (8-13 Hz) power in posterior sites, task-related frontal theta power (4-7 Hz in 140-220 ms post-stimulus), and frontal theta HEBR (3-5 Hz and 265-328 ms post-R-peak). Latent difference score modeling found that only the changes in the frontal theta HEBR mediated the MBSR treatment effect. Brain source-level analysis found that the theta HEBR changes in the anterior cingulate cortex, anterior insular cortex, and the lateral prefrontal cortex predicted PTSD symptom improvements. These results indicated that mindfulness meditation improves spontaneous brain activities reflecting internally oriented relaxation and brain functions of attentional control. However, interoceptive brain capacity enhanced by MBSR appears to be the primary cerebral mechanism that regulates emotional disturbances and improves anxiety symptoms of PTSD.

Comparable studies

Other randomized controlled trials on PTSD, most cited first.

Study Year Design Participants
MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study. Patients with severe PTSD, including those with comorbidities such as dissociation,... 2021 Randomized controlled trial n = 90
The safety and efficacy of {+/-}3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study. Patients with chronic post-traumatic stress disorder refractory to both psychotherapy... 2010 Randomized controlled trial n = 20
Efficacy of Intravenous Ketamine for Treatment of Chronic Posttraumatic Stress Disorder Patients with chronic PTSD related to a range of trauma exposures 2014 Randomized controlled trial n = 41
3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial. Military veterans and first responders aged 18 or older with chronic PTSD lasting 6... 2018 Randomized, double-blind, dose-response, phase 2 clinical trial n = 26
A randomized, controlled pilot study of MDMA (±3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic Post-Traumatic Stress Disorder (PTSD) Patients with treatment-resistant PTSD 2012 Randomized controlled trial n = 12

Explore topics